Figure 1.
Figure 1. Analysis of HDAC6 expression in CLL patient samples. (A) Intracellular HDAC6 protein expression in CD19+ CD5− B cells from normal donors (n = 13) and CD19+ CD5+ B cells from CLL patient peripheral blood samples (n = 38), as determined by flow cytometry. (B) Correlation analyses showing relationship between HDAC6 protein expression and CLL B-cell percentages in CLL patient samples. (C) HDAC6 protein expression in CD38+ or CD38− CLL patient samples. Error bars correspond to standard deviations. *P < .05, **P < .005. MFIR, median fluorescence intensity ratio (value normalized to isotype control).

Analysis of HDAC6 expression in CLL patient samples. (A) Intracellular HDAC6 protein expression in CD19+ CD5 B cells from normal donors (n = 13) and CD19+ CD5+ B cells from CLL patient peripheral blood samples (n = 38), as determined by flow cytometry. (B) Correlation analyses showing relationship between HDAC6 protein expression and CLL B-cell percentages in CLL patient samples. (C) HDAC6 protein expression in CD38+ or CD38 CLL patient samples. Error bars correspond to standard deviations. *P < .05, **P < .005. MFIR, median fluorescence intensity ratio (value normalized to isotype control).

Close Modal

or Create an Account

Close Modal
Close Modal